Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A Multi-Center, Randomized, Double Blind, Placebo-Controlled, ‘add-on’ study to investigate the efficacy and safety of 24 weeks intravenous treatment with QAX576 in patients (≥18-75 years) with persistent asthma not adequately controlled with inhaled corticosteroids and long acting β2-agonists https://kusajili.com:443/Trial/DXFKuRFzQ0KB6kWEkN6GPA%24a-multi-center-randomized-double-blind-placebo-controlled-add-on-study-to-investigate-the-efficacy-and-safety-of-24-weeks-intra
I have read and accept the terms of use of the site and the Privacy Policy
Send your message